Objective Capital Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-659
Closed -$334K 134
2024
Q4
$334K Sell
659
-148
-18% -$84.1K 0.22% 98
2024
Q3
$472K Buy
+807
New +$456K 0.28% 74
2024
Q1
$439K Sell
888
-5
-0.6% -$2.54K 0.3% 71
2023
Q4
$470K Sell
893
-55
-6% -$29.3K 0.36% 61
2023
Q3
$478K Buy
948
+1
+0.1% +$492 0.42% 55
2023
Q2
$455K Sell
947
-21
-2% -$10.3K 0.4% 55
2023
Q1
$457K Buy
968
+29
+3% +$14K 0.42% 52
2022
Q4
$498K Buy
939
+54
+6% +$28.6K 0.49% 50
2022
Q3
$447K Buy
885
+13
+1% +$6.84K 0.48% 52
2022
Q2
$448K Buy
872
+9
+1% +$4.52K 0.45% 52
2022
Q1
$440K Sell
863
-8
-0.9% -$3.86K 0.34% 66
2021
Q4
$437K Buy
+871
New +$394K 0.31% 69

Other funds holding UNH

Objective Capital Management's UNH Position: Q1 2025 in Review

Objective Capital Management sold out of UnitedHealth (UNH) in Q1 2025, closing a stake of 659 shares — an estimated $334K sold.

Objective Capital Management first reported a position in UNH in Q4 2021 and held it in 12 quarters. The position peaked at $498K in Q4 2022. 3,602 funds tracked by Wall St. Rank hold UNH as of Q1 2025.

  • Objective Capital Management reported no remaining UnitedHealth position as of Q1 2025 after selling out during the quarter.
  • Objective Capital Management sold 659 UnitedHealth shares in Q1 2025, an estimated $334K.
  • Objective Capital Management first reported a position in UnitedHealth in Q4 2021 and held it in 12 quarters.
  • Objective Capital Management's UnitedHealth position peaked at $498K in Q4 2022.
  • 3,602 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2025.

Based on Objective Capital Management's 13F filing for Q1 2025, filed 7 May 2025.